Red and Near-Infrared Light Therapy Gains Mainstream Recognition
Red and near-infrared light therapy, once considered an unconventional treatment, is gaining recognition in various medical fields. The global market for these devices is projected to exceed US$1 billion by 2030, driven by both wellness trends and a growing body of scientific evidence.
The global market for these devices is projected to exceed US$1 billion by 2030, driven by both wellness trends and a growing body of scientific evidence.
Early research suggested that red and near-infrared light applied to the head might protect neural tissue after brain injury. Dermatologist David Ozog, for instance, reported positive observations after his son's stroke, becoming a proponent of the therapy despite its initial fringe status.
Scientific Foundations and Evolution
Researchers are exploring the benefits of red-light therapy for several conditions, with clinical studies reporting improvements in peripheral neuropathy, retinal degeneration, and certain neurological disorders. For some indications, expert groups now recommend red-light regimens.
Historically, light's role in human health has been recognized for over a century, including ultraviolet light for vitamin D production and concentrated light for skin tuberculosis. Modern photobiomodulation, using wavelengths from approximately 600 to 1,100 nanometres, emerged in the 1960s with observations of stimulated hair growth in rodents. Interest expanded in the 1990s when NASA scientists noted accelerated wound healing under red LEDs.
Solidifying Clinical Evidence and Approvals
Over the past decade, evidence for red-light therapy has solidified in several clinical areas.
Over the past decade, evidence for red-light therapy has solidified in several clinical areas:
- A 2025 consensus review, involving over 20 specialists, concluded the therapy was safe and effective for various ulcers, peripheral neuropathy, acute radiation dermatitis, and androgenic alopecia (pattern hair loss).
- The US Food and Drug Administration approved a red-light device for dry age-related macular degeneration.
- Since 2020, red-light therapy has been included in clinical guidelines for preventing and treating cancer-therapy-related oral mucositis.
Beyond these established uses, clinical trials report improved muscle recovery in athletes, reductions in depression symptoms, and pain relief for individuals with osteoarthritis and fibromyalgia. Small human trials and animal studies indicate potential benefits for metabolic and cardiovascular diseases, and severe COVID-19 recovery.
Promising Outlook for Brain Health
Some of the most notable early results involve the brain. In mouse models of Parkinson's disease, photobiomodulation applied to the head preserved dopamine-producing neurons. Researchers are conducting human trials, including using optical fibers for targeted light delivery. The development of transcranial devices aims to provide practical methods for treating various psychiatric and neurological diseases.
Unraveling the Mechanisms: Focus on Mitochondria
Research is focusing on mitochondria, the energy-producing organelles in cells, as a central mechanism.
Red to near-infrared light wavelengths can penetrate tissue, with some reaching centimetres deep. These wavelengths are absorbed by cytochrome c oxidase, a key enzyme in the mitochondrial electron transport chain, which can boost the production of adenosine triphosphate (ATP), the cellular fuel. Downstream effects include improved blood flow and changes in inflammation and oxidative stress. One hypothesis suggests red and near-infrared light may reduce water viscosity, aiding mitochondrial function.
Some findings suggest that mitochondria might communicate across the body. The therapy's impact appears stronger in stressed cells or during illness where mitochondrial dysfunction is common, while healthy cells may show little effect. However, mitochondria may not fully explain all therapeutic responses.
Unanswered Questions and Future Directions
Significant aspects remain unresolved, including:
- Optimal wavelengths, intensities, timing, and delivery methods for different conditions.
- The influence of age or skin color on dosage.
- The complete range of biological effects.
Researchers emphasize the importance of finding a biological 'sweet spot' for dosage, avoiding too little or too much light.
Some also advocate for considering a broad spectrum of light, as it occurs in nature, rather than isolated wavelengths.